How we treat advanced biliary tract cancers in the second-line setting

Clin Adv Hematol Oncol. 2023 Jan;21(1):35-42.

Authors

Haley Ellis^{1

2}, Srivatsan Raghavan^{1

2}, Brian M Wolpin^{1

2}, James M Cleary^{1

2}

Affiliations

¹ Dana-Farber Cancer Institute, Boston, Massachusetts.
² Harvard Medical School, Boston, Massachusetts.

PMID: 36638354

No abstract available

MeSH terms

Bile Duct Neoplasms*
Biliary Tract Neoplasms* / drug therapy
Humans